AI Article Synopsis
Article Abstract
Several groups have shown that vaccine antigens can be encapsulated within polymeric microparticles and can serve as potent antigen delivery systems. We have recently shown that an alternative approach involving charged polylactide co-glycolide (PLG) microparticles with surface adsorbed antigen(s) can also be used to deliver antigen into antigen presenting cell (APC). We have described the preparation of cationic and anionic PLG microparticles which have been used to adsorb a variety of agents, which include plasmid DNA, recombinant proteins and adjuvant active oligonucleotides. These PLG microparticles were prepared using a w/o/w solvent evaporation process in the presence of the anionic surfactants, including DSS (dioctyl sodium sulfosuccinate) or cationic surfactants, including CTAB (hexadecyl trimethyl ammonium bromide). Antigen binding to the charged PLG microparticles was influenced by several factors including electrostatic and hydrophobic interactions. These microparticle based formulations resulted in the induction of significantly enhanced immune responses in comparison to alum. The surface adsorbed microparticle formulation offers an alternative and novel way of delivering antigens in a vaccine formulation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/156720106775197565 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A microparticle delivery system for extended release of all-trans retinoic acid and its impact on macrophage insulin-like growth factor 1 release and myotube formation.
Int J Pharm
December 2024
Biomedical Engineering Program, University of South Carolina, Columbia, SC 29208, USA; Department of Chemical Engineering, University of South Carolina, Columbia, SC 29208, USA; Veterans Affairs Medical Center, Columbia, SC 29209, USA. Electronic address:
Article Synopsis
- - Muscle atrophy due to disuse, aging, or illness can lead to increased risks of injury and prolonged recovery, with macrophages playing a crucial role in muscle regeneration by releasing insulin-like growth factor 1 (IGF-1).
- - Researchers encapsulated all-trans retinoic acid (ATRA) in microparticles to improve its bioavailability and promote IGF-1 release from macrophages, enhancing muscle cell formation and regeneration.
- - The study shows that ATRA-PLG microparticles are effectively taken up by macrophages and can stimulate IGF-1 production, supporting further research on its potential use in muscle recovery treatments.
Magnetically powered microwheel thrombolysis of occlusive thrombi in zebrafish.
Proc Natl Acad Sci U S A
March 2024
Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109.
Tissue plasminogen activator (tPA) is the only FDA-approved treatment for ischemic stroke but carries significant risks, including major hemorrhage. Additional options are needed, especially in small vessel thrombi which account for ~25% of ischemic strokes. We have previously shown that tPA-functionalized colloidal microparticles can be assembled into microwheels (µwheels) and manipulated under the control of applied magnetic fields to enable rapid thrombolysis of fibrin gels in microfluidic models of thrombosis.
View Article and Find Full Text PDFMagnetically Powered Microwheel Thrombolysis of Occlusive Thrombi in Zebrafish.
bioRxiv
September 2023
Department of Pediatrics, University of Michigan, Ann Arbor, MI.
Tissue plasminogen activator (tPA) is the only FDA approved treatment for ischemic stroke but carries significant risks, including major hemorrhage. Additional options are needed, especially in small vessel thrombi which account for ~25% of ischemic strokes. We have previously shown that tPA-functionalized colloidal microparticles can be assembled into microwheels (µwheels) and manipulated under the control of applied magnetic fields to enable rapid thrombolysis of fibrin gels in microfluidic models of thrombosis.
View Article and Find Full Text PDFPreparation and Characterization of PLG Microparticles by the Multiple Emulsion Method for the Sustained Release of Proteins.
Micromachines (Basel)
October 2022
Bioplastic Production Laboratory for Medical Application, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Rapid release and diminished stability are two of the limitations associated with the growth factors that are essentially used in dental applications. These growth factors are employed to enhance the quality and quantity of tissue or bone matter during regeneration. Therefore, drug delivery devices and systems have been developed to address these limitations.
View Article and Find Full Text PDFEffect of fabrication parameters on morphology and drug loading of polymer particles for rosiglitazone delivery.
J Drug Deliv Sci Technol
July 2021
Biomedical Engineering Program, University of South Carolina, Columbia, SC 29208, USA.
For the past several decades, drug-encapsulated polymer particles have been investigated as locally-delivered, long-acting therapies. The most common method of producing such particles is the oil in water solvent extraction technique. Using this technique, we produced poly(lactide-co-glycolide) (PLG) microparticles encapsulating rosiglitazone, a small molecule anti-diabetic drug.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!